CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $392,000 | +96.0% | 5,996 | +81.9% | 0.00% | – |
| Q2 2022 | $200,000 | -13.8% | 3,297 | -10.7% | 0.00% | – |
| Q1 2022 | $232,000 | -25.6% | 3,693 | -10.3% | 0.00% | – |
| Q4 2021 | $312,000 | -65.6% | 4,116 | -49.1% | 0.00% | -100.0% |
| Q3 2021 | $906,000 | -16.2% | 8,094 | +21.2% | 0.00% | -50.0% |
| Q2 2021 | $1,081,000 | +24.0% | 6,678 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $872,000 | -16.4% | 7,156 | +5.1% | 0.00% | 0.0% |
| Q4 2020 | $1,043,000 | +224.9% | 6,811 | +77.4% | 0.00% | +100.0% |
| Q3 2020 | $321,000 | -2.4% | 3,839 | -14.2% | 0.00% | 0.0% |
| Q2 2020 | $329,000 | +39.4% | 4,473 | -19.9% | 0.00% | 0.0% |
| Q1 2020 | $236,000 | – | 5,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |